Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Johnston

Showing results (61-70 of 136) with videos related to

Pageof 14
Sort By:
Steroids|April 12, 2011
An in vitro model showing adaptation to long-term oestrogen deprivation highlights the clinical potential for targeting kinase pathways in combination with aromatase inhibitionL-A Martin, Z Ghazoui, M T Weigel, et al.
Obesity Surgery|June 17, 2026
Knotless tissue control devices for hand-sewn gastrojejunostomy in robotic-assisted Roux-en-Y gastric bypassStephen Johnston, Najmuddin Gunja, Aakash Jha, et al.
The Oncologist|February 17, 2010
Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor-positive metastatic breast cancerLee S Schwartzberg, Lee S Schwarzberg, Sandra X Franco, et al.
Administration and Policy in Mental Health|March 18, 2008
Enhancing the net benefits of disseminating efficacious prevention programs: a note on target efficiency with illustrative examplesDavid S Salkever, Stephen Johnston, Mustafa C Karakus, et al.
Cancers|June 26, 2026
Thermal Ablation of Breast Cancer Liver Metastases Is Associated with Durable Local Control and Chemotherapy-Free Intervals in Selected PatientsNiaz Ahmed, Alicia Okines, Sophie McGrath, et al.
JNCI Cancer Spectrum|June 27, 2023
Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differencesStephen Johnston, Anna Emde, Carlos Barrios, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|October 16, 2012
An improved experimental model for understanding the impact of sperm DNA fragmentation on human pregnancy following ICSIRocio Nuñez-Calonge, Pedro Caballero, Carmen López-Fernández, et al.
Theriogenology|June 10, 2026
Zinc chelation and supplementation to enhance artificial oocyte activation efficiency in the bovineRhiannon J Gurkin, Pablo Andrés Segura Forero, Patricio D Palacios, et al.
Clinical Breast Cancer|July 15, 2022
Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-ResistanceAlicia F C Okines, Tazia Irfan, Kabir Mohammed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2013
Quantitative ER and PgR assessment as predictors of benefit from lapatinib in postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancerRichard S Finn, Michael F Press, Judy Dering, et al.
Pageof 14

Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Steroids|April 12, 2011
An in vitro model showing adaptation to long-term oestrogen deprivation highlights the clinical potential for targeting kinase pathways in combination with aromatase inhibitionL-A Martin, Z Ghazoui, M T Weigel, et al.
Obesity Surgery|June 17, 2026
Knotless tissue control devices for hand-sewn gastrojejunostomy in robotic-assisted Roux-en-Y gastric bypassStephen Johnston, Najmuddin Gunja, Aakash Jha, et al.
The Oncologist|February 17, 2010
Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor-positive metastatic breast cancerLee S Schwartzberg, Lee S Schwarzberg, Sandra X Franco, et al.
Administration and Policy in Mental Health|March 18, 2008
Enhancing the net benefits of disseminating efficacious prevention programs: a note on target efficiency with illustrative examplesDavid S Salkever, Stephen Johnston, Mustafa C Karakus, et al.
Cancers|June 26, 2026
Thermal Ablation of Breast Cancer Liver Metastases Is Associated with Durable Local Control and Chemotherapy-Free Intervals in Selected PatientsNiaz Ahmed, Alicia Okines, Sophie McGrath, et al.
JNCI Cancer Spectrum|June 27, 2023
Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differencesStephen Johnston, Anna Emde, Carlos Barrios, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|October 16, 2012
An improved experimental model for understanding the impact of sperm DNA fragmentation on human pregnancy following ICSIRocio Nuñez-Calonge, Pedro Caballero, Carmen López-Fernández, et al.
Theriogenology|June 10, 2026
Zinc chelation and supplementation to enhance artificial oocyte activation efficiency in the bovineRhiannon J Gurkin, Pablo Andrés Segura Forero, Patricio D Palacios, et al.
Clinical Breast Cancer|July 15, 2022
Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-ResistanceAlicia F C Okines, Tazia Irfan, Kabir Mohammed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2013
Quantitative ER and PgR assessment as predictors of benefit from lapatinib in postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancerRichard S Finn, Michael F Press, Judy Dering, et al.
Pageof 14